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Christopher M. A. Parlett, a Karen Wilson *a and Adam F. Lee *a
Silica encapsulated silver nanoparticle core–shell nanocomposites of tunable dimensions were synthesised
via a one-pot reverse microemulsion route to achieve controlled release of Ag+ ions for broad spectrum
antibacterial application. Silver release rates and bactericidal eﬃcacy against Gram-positive and Gram-
negative bacteria, S. aureus and P. aeruginosa respectively, were inversely proportional to nanoparticle
core diameter (3–8 nm) and silica shell (7–14 nm) thickness, and readily tuned through a facile
hydrothermal etching protocol employing a PVP stabiliser to introduce mesoporosity.Introduction
Healthcare associated infections (HCAI's) are illnesses resulting
from a patient's stay within a hospital environment, and
a matter of global concern, aﬀecting up to 25% of patients in
European clinics and costing billions of dollars.1,2 Around 4
million people per year acquire a HCAI within Europe,
accounting for approximately 37 000 deaths.3 Staphylococcus
aureus has attracted particular attention due to its rapid devel-
oped resistance to conventional antibiotics; 10% of this bacte-
rium exhibits methicillin-resistance (MRSA) across 19 of the 29
European economic area (EEA) countries.4
Silver has a long history5–7 as an eﬀective, broad spectrum
antimicrobial in ionic, complex and bulk presentations.8–10 In
contemporary times, advances in nanotechnology have led to
a focus on the application of silver nanoparticles in combating
drug-resistant bacteria.11–14 Systematic studies of silver nano-
particles deposited onto carefully selected supports suggest that
tuning the properties of silver containing nanocomposites can
lead to systems with variable dissolution rates, and in turn,
eﬀective antimicrobial lifetimes and strengths.12,15–17
Core–shell nanocomposites were developed in the 1990s18,19
and have found application within catalysis,20 spectroscopy21
and antimicrobials.22 In the latter case, there has been signi-
cant interest in the development of nanocomposites comprising
silver nanoparticle cores encapsulated by inert oxides as
a means to improve the thermal stability, sinter resistance and
release kinetics of antimicrobial, soluble silver ions.23–25on University, Birmingham, B4 7ET, UK.
.ac.uk
Birmingham, B4 7ET, UK
a, Italy
n (ESI) available: Physicochemical
antimicrobial testing. See DOI:
7Silver@silica materials have proven popular due to the relative
simplicity of silica syntheses and low cost of associated alkoxide
precursor compared with other metal oxides, and ease of
introducing porosity via sacricial organic templates.26,27 Silver
has also been encapsulated within titania shells, adding pho-
tocatalytic degradation of pathogens (bacteria, moulds, viruses)
and cancer cells28 to the mode of antimicrobial action oﬀered by
ionic Ag. However, the relationship between nanocomposite
dimensions and silver release rates, critical to determining both
the eﬃcacy and longevity of associated antimicrobial perfor-
mance, has never been quantied.
Here, two families of Ag@SiO2 core–shell nanocomposites
were prepared possessing independently varying core diam-
eter or shell thickness, to address structure–function and
bioactivity relations, and the impact of post-synthetic etching
protocols.Experimental
Nanocomposite synthesis
Briey, silver nanoparticles were formed and encapsulated in
a one-pot reverse microemulsion method adapted from Li
et al.29 as described in Fig. S1.† A microemulsion solution was
prepared from cyclohexane (Sigma Aldrich $99%), Igepal co-
520 (Sigma Aldrich) and deionised water in an aluminium
foil-covered 250 ml round bottomed ask with vigorous stirring
(750 rpm) at room temperature under owing N2. Silver nitrate
solution (0.1 M, Sigma Aldrich) was added and the solution le
to equilibrate for 20 min. Hydrazine (Sigma Aldrich 50–60% vol)
was added to reduce the silver. Aer 5 min stirring, ammonium
hydroxide (Sigma Aldrich 35%) was added, followed by tet-
raethyl orthoxysilicate (TEOS, Sigma Aldrich 98%). The solution
was stirred at 750 rpm for 24 h under owing nitrogen (1 ml
min1) and the resulting microemulsion subsequently diluted
with ethanol (Fisher 98%) to give a 1 : 1 molar ratio ofThis journal is © The Royal Society of Chemistry 2017
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View Article Onlineethanol : cyclohexane, then centrifuged at 6000 rpm for 8 min
to separate the particulate phase and the solution decanted.
Particulates were re-dispersed in a 50 : 50 vol% water : ethanol
mixture by ultrasonication and the resulting sol again separated
by centrifugation and washed twice more with a water/ethanol
mixture to obtain a solid powder which was nally calcined at
500 C for 4 h employing a ramp rate of 5 C min1.
Nanocomposite characterisation
XRD analysis was performed on a Bruker D8 advance diﬀrac-
tometer using Cu Ka X-ray radiation (0.15418 nm), with a Lyn-
xEYE high speed strip detector and calibrated against
a corundum standard. Volume averaged crystallite diameters
are reported. Diﬀraction patterns were recorded between 2q ¼
10–80 in 0.01 steps. N2 porosimetry was performed on
a Quantachrome Nova 4000 porosimeter, on samples degassed
under vacuum at 120 C for 2 h. Mesopore analysis was per-
formed applying the BJH method to the desorption branch of
the isotherm, and the t-plot method applied to calculate
microporosity. Data was analysed using NovaWin version 11.
UV-Vis measurements were performed in water using a Thermo
evolution 220 UV-Vis spectrophotometer.
XPS analysis was recorded using a Kratos Axis HSi X-ray
photoelectron spectrometer utilising Al Ka (1486.6 eV) and Mg
Ka (1253.6 eV) radiation and amagnetic charge neutraliser, with
inelastic mean free paths obtained from the LA Surface data-
base30,31 to determine silica shell thickness non-destructively.
Spectra were energy referenced to adventitious carbon at
284.6 eV and analysed using CasaXPS version 2.3.15 with
quantication using appropriate instrumental response factors.
Ag 3d XP spectra were tted to a Doniach–Sunjic peakshape,
with a spin–orbit split doublet separation of 6 eV. Silica shell
thickness was estimated from the relative intensities of Ag 3d
photoelectrons excited by either Al or Mg Ka X-rays.
Bulk elemental analysis was undertaken using ICP-MS per-
formed by MEDAC Ltd. HRTEM analysis was performed using
a JEOL 2100 microscope with a LaB6 source and 180 kV accel-
eration. Samples were prepared using a drop casting method in
ethanol onto continuous carbon grids. Particle sizing was per-
formed using ImageJ 1.46r soware. Particle size distributions
were produced from counts of a minimum of 100 particles.
Dissolution proles were developed by stirring 10 mg of
Ag@SiO2 core–shell nanocomposites in 25 ml of 0.5 M NaNO3
with periodic aliquots of the analyte solution measured for
silver content using an Agilent 6130B single Quad (ESI) ICP-MS,
calibrated against a range of silver concentrations made by
serial dilution of a 1000 ppm Ag in 1% HNO3 standard (Sigma-
Aldrich). Silver release rates were calculated using the initial
rates of the dissolution proles over the linear portion of the
proles (typically the rst 30 min of immersion).
Nanocomposite etching
Ag@SiO2 core–shell nanocomposites were hydrothermal etched
by mixing 100 mg of Ag@SiO2 core–shell material with 250 mg
PVP (Sigma Aldrich, Mr ¼ 40 000) in 25 ml H2O and heated at
95 C for 3 h in a 50ml round bottom ask. The resulting etchedThis journal is © The Royal Society of Chemistry 2017material was subsequently ltered, washed three times with
ethanol then dried overnight at 100 C.32
Ag@SiO2 core–shell nanocomposites were also base etched
by mixing 500 mg of Ag@SiO2 core–shell material with 2 g of
PVP (Sigma Aldrich, Mr ¼ 40 000) in 150 ml H2O and stirred
overnight. To this slurry, 20 ml of 0.1 M NaOH was added under
continuous stirring, and solid samples periodically removed,
ltered, washed three times with water and three times with
ethanol prior to drying overnight at 100 C.33Antibacterial testing
The antibacterial performance of Ag@SiO2 core–shell nano-
composites was evaluated against Staphylococcus aureus ATCC
6538, MRSA ATCC 33591, Escherichia coli NCTC 10418, Bacillus
subtilis NCTC 8236, Pseudomonas aeruginosa ATCC 15442 and
Clostridium diﬃcile ATCC 9689 which are representative Gram-
positive and Gram-negative problematic organisms found in
hospital environments. Zone of inhibition (ZoI) tests were per-
formed by inoculating the surface of a nutrient agar plate
(Oxoid, Basingstoke UK) with an excess volume (3 ml) of
nutrient broth which had previously been inoculated and
incubated to a cell density of 108 cfu ml1 as determined
spectrophotometrically using a Perkin-Elmer lambda 10 UV-Vis
spectrophotometer. The liquid was manipulated by agitation to
provide a conuent inoculum and the excess uid removed to
waste using a sterile pipette. Using a sterilised boring tool, 5
mm holes were then bored into the agar, and 100 ml of a solu-
tion of 10 mg of Ag@SiO2 core–shell nanocomposite in 5 ml of
simulated body uid (SBF, see Table S1†) dispensed into the
borehole using a calibrated micropipette. SBF was prepared
according to a method from Kokubo et al.34 750 ml of deionised
water was stabilised at 37 C with stirring, to this the following
ions were added: NaCl (7.996 g, Sigma Aldrich >99%), NaHCO3
(0.35 g, Sigma Aldrich >99%), KCl (0.224 g, Sigma Aldrich
>99%), K2HPO4$3H2O (0.228 g, Sigma Aldrich >99%), MgCl2
(0.305 g, Sigma Aldrich >99%), HCl (40 ml, 1 kmol l1, Fisher
scientic 37%), CaCl2 (0.278 g, Sigma Aldrich >99%), Na2SO4
(0.071 g, Sigma Aldrich >99%) and (CH2OH)3CNH2 (6.057 g,
Sigma Aldrich 99%). Finally, the pH was adjusted to 7.35 using
HCl solution (1 kmol l1, Fisher scientic 37%). Plates were
then incubated at 37 C overnight, photographed, and cali-
brated zone areas determined using ImageJ soware.
Quantitative antimicrobial activity was determined by loga-
rithmic reduction.15,16 Here, 5 mg of Ag@SiO2 core–shell
nanocomposite material was added to an Eppendorf tube con-
taining 1 ml of either S. aureus or P. aeruginosa in a nutrient
broth at concentrations of 107 cfu ml1. 100 ml aliquots of the
resulting suspensions were subsequently removed at 0, 60,
240 min and 24 hours, and added to a 1 ml solution of Tween 20
(supplier, 1%), sodium dodecyl sulphate (supplier 0.4%) and
sodium chloride (0.85%) to neutralise any soluble silver
species.15,16 Each of the resulting neutralised solutions was
serially diluted with phosphate buﬀered saline (PBS) prior to
plating onto agar and incubation at 37 C for 24 h. The exper-
iments were all run with positive and negative controls of silver
nitrate and without any nanocomposite respectively. AerRSC Adv., 2017, 7, 23342–23347 | 23343
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View Article Onlineincubation, the number of colonies present on the agar was
counted by visual inspection, and normalised relative to the
initial colony count in the negative control at time t ¼ 0 min to
determine the logarithmic reduction of bacteria. All experi-
ments were performed in triplicate, with mean values and
standard deviations reported.Results and discussion
Successful synthesis of the desired core–shell architecture was
conrmed in all cases through HRTEM as illustrated in Fig. 1.
The silver core size was controlled through varying the [water]-
: [surfactant] molar ratio (Wo); the diameter of the micelles and
resulting silver nanoparticles was directly proportional to the
water content (Fig. S2–S4†). The minimum core size of 3.5  0.5
nm thus obtained is the smallest reported for such a core–shell
composites. Control over the encapsulating silica shell thick-
ness was achieved through varying the [water] : [TEOS] molar
ratio (H); the silica shell thickness was directly proportional to
the TEOS concentration (Fig. S5–S7†).
Fig. 1 demonstrates complete encapsulation of, and the
sharp interface between, silver core and silica shell for
a Ag@SiO2 nanocomposite possessing a 7.5  0.5 nm core and
9.5  1.2 nm thick shell by HRTEM. UV-Vis spectroscopy
revealed a characteristic feature at 410 nm arising from the
surface plasmon resonance associated with silver nanoparticlesFig. 1 HR-STEMmicrograph of representative Ag@SiO2 core–shell nano
0.5 nm, mean SiO2 shell thickness ¼ 9.5  1.2 nm, and clockwise from
composite, and (b) Ag 3d : Si 2p XP surface atomic ratio and Ag+ relea
(common mean Ag core diameter ¼ 4.5  0.4 nm) and (d) silver core d
23344 | RSC Adv., 2017, 7, 23342–23347(Fig. S8†). Powder XRD conrmed fcc silver metal (Fig. S9,†
JCPDS no. 04-0783) as the only crystalline phase within the
composite, in accordance with the observation of Ag(111) lattice
fringes in Fig. 1. Corresponding volume averaged core diame-
ters shown in Fig. 1, estimated from silver reections using the
Scherrer equation, were in good agreement with those from
TEM (Fig. S9†). In contrast, Ag 3d XP spectra of all nano-
composites were dominated by a single spin–orbit doublet with
3d5/2 binding energy of 367.9 eV (Fig. S11†), consistent with Ag
+
present in Ag2O, which exhibits an anomalous low binding
energy shi with respect to silver metal.35 XPS was also
employed to estimate the average silica shell thickness through
comparing the Ag 3d intensity obtained under excitation by two
diﬀerent X-ray wavelengths (resulting in diﬀerent photoelectron
escape depths) as previously employed for Pt/PtOx 36 and Pd/
PdOx 35,37 core–shell nanoparticles. The resulting shell thick-
nesses determined by XPS and reported in Fig. 1 were in good
quantitative agreement with local HRTEM measurements
(Fig. S12†). In order to understand the apparent discrepancy
between the observation of predominantly ionic silver by
surface sensitive XPS, and of metallic silver by XRD and
HRTEM, Ag K-edge XANES were subsequently recorded to probe
the chemical state of all silver species within a representative
nanocomposite possessing a 4.5  0.4 nm diameter silver core
and 9.5  1.2 nm thick SiO2 shell (Fig. 1 and S13†). Linear
combination tting of the XANES to silver metal, Ag2O and AgOcomposite with silver lattice fringes shown inset (mean Ag core¼ 7.5
top left). (a) Fitted Ag K-edge XANES spectra of corresponding nano-
se rate from nanocomposite as a function of (c) silica shell thickness
iameter (common mean SiO2 shell ¼ 9.5  1.2 nm thick).
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinestandards revealed that while the majority of silver in the
nanocomposite was present as the metal, approximately 20%
was present as Ag+, in excellent quantitative agreement with the
proportion predicted for a single layer of electronically per-
turbed silver atoms in the silver core at the interface with the
silica shell (as described in the ESI†). This ionic silver likely
serves as the initial reservoir for dissolved silver species upon
immersion in aqueous media.
The impact of Ag@SiO2 nanocomposite structure on the
kinetics of silver dissolution, expected to strongly inuence
their resulting antimicrobial performance, was subsequently
investigated. Initial Ag+ release rates determined from the
dissolution proles in aqueous 0.5 M NaNO3 (Fig. S14†) are
shown normalised to the mass of silver within each parent
nanocomposite in Fig. 1. Previous studies on citrate and thiol
functionalized methoxyl polyethylene glycol stabilised Ag
nanoparticles report that the rate of oxidative silver dissolution
is inversely proportional to particle diameter.27,38 These
Ag@SiO2 core–shell nanocomposites exhibit a similar inverse
relationship between silver core size and release rate, conrm-
ing that the geometric surface area of the core was rate-
determining for Ag+ dissolution, with a rate constant of
14.664 mmol1 h nmcore
1 gAg
1 (Fig. S15†). In contrast, the rate
of Ag+ release exhibited an inverse linear dependence on silica
shell thickness (Fig. S16†), suggesting a common diﬀusivity
(and hence shell porosity) independent of shell thickness, such
that dissolution is simply a function of the path length from the
core to the shell exterior with a rate constant of 0.58 mmol1 h
nmshell
1 gAg
1. Extrapolating to a bare 4.5  0.4 nm diameter
silver core yields a predicted maximum release rate of 8.55 mmol
h1 gAg
1, almost identical to that of 8.9 mmol h1 gAg
1 esti-
mated from the literature for the same diameter (stabilised)
silver nanoparticles.27,38
In light of the independence of Ag+ diﬀusivity on silica shell
thickness, the 4.5 0.4 nm diameter silver core and 9.5 1.2 nm
thick SiO2 shell nanocomposite was subsequently subjected to
either hydrothermal32 or base etching pre-treatments33 (Fig. 2) in
order to modify shell porosity and hence further control release
kinetics. Neither pre-treatment inuenced the silver core or silica
shell dimensions (Fig. S16†), or the predominantly metallicFig. 2 Schematic of post-synthetic treatment of Ag@SiO2 nano-
composites: (top) hydrothermal etching, (bottom) base etching.
This journal is © The Royal Society of Chemistry 2017nature of the crystalline core (Fig. S17†). However, base etching
completely removed silver cores from a signicant fraction of
nanocomposite particles (up to 14%), proportional to the etching
time (Fig. S18†); hydrothermal etching proved milder, removing
only 3% of silver cores. The loss of silver from the nanocomposite
through base etching can be rationalised in terms of the
concomitant dramatic rise in surface area and pore diameter
(Fig. S19†), accompanied by an apparent inhomogeneity in the
appearance of silica shells (Fig. S16†), indicative of an open
micro/mesoporous shell through which silver dissolution is
facile. Hydrothermal etching had minimal impact on surface
area, but increased the pore volume of the nanocomposite 10-
fold (Fig. S19†).
The loss of silver cores accompanying base etching signi-
cantly reduced the subsequent availability of soluble silver
(Fig. S14 and S20†), an eﬀect proportional to etching time,
whereas hydrothermal pre-treatment enhanced total silver
release by almost 50% aer 24 h due to the improved
mesoporosity.
Ag@SiO2 nanocomposites were subsequently quantitatively
assayed against Staphylococcus aureus ATCC 6538 and Pseudo-
monas aeruginosa ATCC 15442, Gram-positive and Gram-
negative bacteria respectively which are major pathogens in
burns and dermal wounds,39–41 by the logarithmic reduction
method in which one log reduction unit represents a 90% kill
eﬃciency. All materials exhibited essentially complete bacterial
death for both strains aer 24 h incubation, hence performance
was compared aer 1 (S. aureus) and 4 h (P. aeruginosa) incu-
bation. The longer assay time for the Gram-negative P. aerugi-
nosa reects the lower permeability of silver ions through the
cell wall and membrane of this strain,42 increasing its antimi-
crobial resistance.26 Fig. 3, shows the impact of varying core
diameter and shell thickness on the resulting log10 reductions,
normalised to the mass of silver in each nano composite. Kill
tests mirrored the silver release rates in Fig. 1, with the smallest
cores enhancing bactericidal performance between 7- and 10-
fold relative to the largest, and the thinnest shells oﬀering
between a 4- and 29-fold enhancement. Additional control over
the eﬃcacy of these Ag@SiO2 nanocomposites was achievable
through etching of the silica shell. As anticipated from their Ag+
release behaviour (Fig. S20†), hydrothermal etching increased
the antimicrobial performance 4-fold for S. aureus and 5-fold for
P. aeruginosa, whereas base etching strongly suppressed this, by
as much as 20-fold for P. aeruginosa (a reection of the lower
silver content following the latter aggressive pre-treatment).
Broad spectrum antimicrobial eﬃcacy of the 4.5  0.4 nm
diameter silver core and 9.5  1.2 nm thick SiO2 shell nano-
composite was nally examined through semi-quantitative
Zone of Inhibition experiments. Fig. 4 demonstrates that the
Ag@SiO2 nanocomposite was potent against a variety of Gram-
positive (S. aureus, MRSA, C. diﬃcile, B. subtilis) and Gram-
negative (P. aeruginosa, E. coli) bacteria in SBF.34
The toxicity of our nanocomposites towards eukaryotic cells
will be the subject of future studies. However, we note that
at sizes comparable to those of the nanocomposites in this work
(7 nm), silver nanoparticles are deemed non-toxic towards
human skin cells at concentrations <6.25 mg ml1, above whichRSC Adv., 2017, 7, 23342–23347 | 23345
Fig. 3 Mass-normalised bacterial kill tests as a function of (left) silver core diameter (common mean SiO2 shell thickness 9.5  1.2 nm), (middle)
SiO2 shell thickness (commonmean silver core diameter¼ 4.5 0.4 nm) against S. aureus ATCC 6538 and P. aeruginosa ATCC 15442, and (right)
hydrothermal or base etching pretreatment (common mean silver core diameter ¼ 4.5  0.4 nm and SiO2 shell thickness ¼ 9.5  1.2 nm). Data
after 1 and 4 h incubation of S. aureus ATCC 6538 and P. aeruginosa ATCC 15442 respectively.
Fig. 4 ZoI assays of a Ag@SiO2 nanocomposite (mean silver core 4.5
0.4 nm and SiO2 shell thickness ¼ 10.5  1.2 nm) against Staphylo-
coccus aureus ATCC 6538, MRSA ATCC 33591, Escherichia coli NCTC
10418, Bacillus subtilis NCTC 8236, Pseudomonas aeruginosa ATCC
15442 and Clostridium diﬃcile ATCC 9689.
RSC Advances Paper
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View Article Onlineoxidative stress occurs through the generation of reactive
oxygen species.43 Silica encapsulation in the present nano-
composites slows the release of soluble silver species by over an
order of magnitude relative to naked silver nanoparticles, and
hence is extremely unlikely to prove damaging in treating skin
cells in wound care applications.
Ionic silver exhibits dramatically increased toxicity towards
mammalian cells in comparison to its nanoparticulate form,44,45
although in vivo protein binding of free Ag+ greatly suppresses its
toxicity.45 Silica nanoparticle toxicity is highly cell dependant,
with half maximal inhibitory concentrations (IC50) towards
macrophages (for similar sized particles to our nanocomposites)23346 | RSC Adv., 2017, 7, 23342–23347of around 73 mg ml1: surface modication by facile silicon-
alkoxide-based methodologies can drastically improve biocom-
patibility and cell viability.46
Conclusions
Systematically related families of Ag@SiO2 core–shell nano-
composites were synthesised through a reverse microemulsion
route which enabled independent control over the silver core
and silica shell dimensions. Bulks and surface sensitive X-ray
spectroscopies indicate that metallic silver cores terminate in
a Ag2O-like phase at the sharply delineated interface with the
silica shell, which likely provides a reservoir for soluble ionic
silver. Mass normalised rates of silver dissolution from the
nanocomposites are inversely proportional to core diameter, i.e.
a simple function of the core surface area : volume ratio, and
display an inverse linear dependence on shell thickness
consistent with a xed porosity. Post-synthetic etching improves
permeability of the silica shell, however base treatments
enhance the shell porosity to such an extent that entire silver
cores are lost from the nanocomposite resulting in poor
subsequent antibacterial performance. In contrast, hydro-
thermal etching appears suﬃciently mild to increase the shell
porosity to permit faster silver dissolution while retaining
a protective barrier against total core loss. Ionic silver dissolu-
tion kinetics mirrored their corresponding quantitative anti-
bacterial eﬃcacy against Gram-positive S. aureus ATCC 6538
and Gram-negative P. aeruginosa ATCC 15442, suggesting
a facile route to the future design of nanocomposites possessing
predicable activities and lifetimes. Future investigations will
also explore the potential fungicidal properties of these
Ag@SiO2 nanocomposites.
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